Press Releases :: Hancock Jaffe Laboratories, Inc. (HJLI)

Hancock Jaffe Laboratories (NASDAQ: HJLI) Featured in Proactive Investors Interview

Apr 16, 2019

Hancock Jaffe Successfully Completes Four VenoValve Implantations for First-in-Human Study

Apr 11, 2019

Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study

Mar 21, 2019

Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute

Mar 18, 2019

Hancock Jaffe Completes $2.7 Million Private Placement of Common Stock

Mar 13, 2019

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

Feb 19, 2019

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

Jan 28, 2019

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

Jan 15, 2019

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

Jan 9, 2019

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

Dec 17, 2018

Show / Refresh / Reset / Delete

Views until show: 5
Seconds until show: 5